Instylla completes enrollment of landmark hypervascular tumor pivotal study. Clinical investigators achieve significant milestone by enrolling 150 patients with various hypervascular tumors in randomized study. #interventionalradiology #interventionaloncology #clinicaltrials

5/5 Tune in for the full conversation with Amar here: medsider.com/interviews/ama…

Instylla's Premarket Approval (PMA) application for Embrace™ Hydrogel Embolic System submitted to FDA. #RegulatoryAffairs #HealthcareInnovation #interventionalradiology instylla.com/instylla-embra…

Join us at #SIR25NASH (Mar 29- Apr 2)! Instylla is excited to share the possibilities of Embrace™ HES! Check out the late-breaking abstracts in 201 AB, on Sun, Mar 30 at 3 pm, and visit us at booth #720. #interventionalradiology #interventionaloncology #clinicaltrials

Don’t miss Dr. Nadine Abi-Jaoudeh 's presentation at #SIR25NASH on the Instylla pivotal study results in Room 201 AB, Sun, March 30, @ 3 pm and visit us at booth #720 to learn about Embrace™ HES. #interventionalradiology #interventionaloncology #clinicaltrials

Thanks for visiting #Instylla at #SIR25NASH. It was exciting to discuss Embrace HES’s late-breaking clinical trial data and the possibilities of Embrace™ HES as a next-generation liquid embolic. #interventionalradiology #interventionaloncology #latebreaking #clinicaltrial

Day 1 of #GEST2025, visit @Instylla at Booth #107 to explore Embrace™ HES & Tembo™ embolic system. 📅 Sat 5/17, 8:30–10 AM — don’t miss the Liquid Masterclass (Metro East Ballroom, 2nd floor)! #MedicalInnovation #interventionalradiology #interventionaloncology #Embolization

Thanks for visiting #Instylla at #GEST2025. It was exciting to discuss our resorbable embolics, Embrace HES and the Tembo Embolic System. #MedicalInnovation in #interventionalradiology, #interventionaloncology, #Embolization

Instylla Welcomes #MedTech Leader, Sean Boyle, as Chief Executive Officer! #interventionalradiology #leadership #embracehes shorturl.at/DjUnl

Instylla announces PMA approval for Embrace™ Hydrogel Embolic System, a novel liquid embolic. A milestone for embolization & IO. #PMA #MedTech #IO #Embolization #IR shorturl.at/H5Rzm

Join us on Saturday, Oct 18, at the Shelborne in Miami Beach @ 7:30 pm ET for dinner and a presentation event with Dr. David Tahour and Dr. Edgar St. Amour. Learn about the future of liquid embolics, the Embrace HES. Reserve your seat here. shorturl.at/4hruP

🎯 10 days to #CIO2025! Join us in Miami at Booth #103 to see Embrace™ HES—the first FDA-approved liquid embolic for hypervascular tumors, backed by a prospective randomized trial. #InterventionalOncology #IR #Embolization #EmbraceHES

A Time to Embrace—the future of liquid embolics is here. Stop by Booth #103 to see Embrace™ HES, the first FDA-approved liquid embolic for hypervascular tumors, proven in a prospective randomized trial. #CIO2025 #InterventionalOncology #IR #Embolization #EmbraceHES

Thanks for visiting #Instylla at #CIO2025. We enjoyed connecting and discussing Embrace™ HES! #ConfidenceinEveryCast #InterventionalOncology #Embolization #medicalinnovation #interventionalradiology #EmbraceHES